Therefore, the obtained results require further confirmation in larger cohorts, especially with regards to alleles with a small number of carriers, mainly B*42:01 and DRB1*11:02 for the risk of symptomatic COVID-19 and DRB1*08:01 for the decreased risk of severe COVID-19. This evidence concerns the gene HLA-DRB1 and COVID-19.